What to Know About Wegovy for Weight Loss

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a medication originally developed for type 2 diabetes that has shown remarkable results for weight loss, with clinical trials demonstrating average weight reductions of 15% to 22% of body weight. This injectable GLP-1 receptor agonist works by slowing stomach emptying, increasing feelings of fullness, and signaling the brain to reduce appetite. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies to help eligible individuals access this therapy affordably and conveniently.

How Semaglutide Works to Reduce Weight

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone that controls blood sugar and appetite. When injected, the medication activates GLP-1 receptors in your brain and digestive tract, triggering multiple weight-loss mechanisms. These include delayed gastric emptying (food moves more slowly from your stomach), reduced hunger signals, and increased satiety—meaning you feel satisfied with smaller portions. The net result is a significant decrease in calorie intake without requiring willpower-dependent restriction.

Beyond appetite suppression, semaglutide also improves how your body processes glucose and lipids. This dual action—reduced food intake plus metabolic improvement—explains why semaglutide produces weight loss even in people without diabetes. Studies show that people using semaglutide maintain their weight loss better than those who diet alone, because the medication addresses the biological drivers of hunger rather than relying on behavioral change alone.

Clinical Evidence for Semaglutide Weight Loss Results

The STEP trials, a series of large clinical studies published between 2021 and 2022, demonstrated semaglutide's effectiveness across diverse patient populations. In STEP 1, people taking the highest dose of semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. STEP 3 enrolled participants with obesity and at least one weight-related condition (such as high blood pressure or cardiovascular disease), and those on semaglutide achieved 16% average weight loss. These results are comparable to or exceed many bariatric surgery outcomes, without requiring anesthesia or permanent anatomical changes.

Real-world data from clinical practices shows that semaglutide weight loss plateaus typically occur around 6 months, but the weight remains off as long as treatment continues. When people stop the medication, some gradual weight regain occurs; however, many retain 50% or more of the weight they lost. This pattern has led doctors to view semaglutide as a long-term maintenance therapy rather than a short-term intervention, similar to how blood pressure medications are used indefinitely.

Who Might Benefit Most from Semaglutide Treatment

Semaglutide is typically prescribed for adults with a body mass index (BMI) of 27 or higher who have at least one weight-related health condition, or a BMI of 30 or higher regardless of other conditions. This includes people with prediabetes, type 2 diabetes, high blood pressure, heart disease, or sleep apnea. However, semaglutide has also shown benefit for people seeking weight loss and improved metabolic health even without diagnosed obesity-related conditions, as it addresses the underlying appetite and glucose dysregulation that drive weight gain. PlexusDx evaluates each patient's health history and current medications to determine eligibility and optimal therapy.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Common Side Effects and Safety Considerations

The most frequent side effects of semaglutide are gastrointestinal and typically mild to moderate: nausea, vomiting, diarrhea, or constipation. These effects usually peak when you start the medication or increase your dose, then improve within days to weeks as your body adjusts. Nausea occurs in about 25% to 40% of users in clinical trials, but only 1% to 2% discontinue the medication because of it. Starting at a low dose and increasing gradually—a process called titration—minimizes side effects. PlexusDx works with compounding pharmacies to ensure your dose increases slowly and safely.

Rare but serious risks include pancreatitis (inflammation of the pancreas), gallbladder problems, and a condition called retinopathy worsening in people with type 2 diabetes. Semaglutide is not recommended for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. Before starting, tell your healthcare provider about all medications, supplements, and past medical conditions. PlexusDx requires a consultation with a licensed practitioner who reviews your history and monitors your progress, ensuring safe and effective therapy.

Semaglutide Access and Cost at PlexusDx

PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies to all 50 states, with no insurance requirement and no membership fee. Treatment is $189 per month month-to-month—your dose may need to go up, but your price won't. This flat-rate pricing removes the financial barrier that makes branded Wegovy (which costs $1,000+ per month) inaccessible to many people. Compounded semaglutide meets the same quality and purity standards as brand-name versions but at a fraction of the cost, because it is manufactured by licensed pharmacies rather than large pharmaceutical companies.

PlexusDx accepts HSA and FSA funds, making treatment tax-advantaged for eligible individuals. After your initial consultation and first month of treatment, you can add the Precision Peptide Genetic Test for $298 to unlock personalized insights into your peptide pathways and genetic predispositions to weight, appetite, and metabolism. This combination—affordable medication plus genetic guidance—gives you the science-backed tools to achieve lasting weight loss. Getting started takes minutes: complete your health assessment online, connect with a licensed practitioner, and receive your compounded medication shipped directly to your home.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as safe and effective as brand-name Wegovy?

Yes. PlexusDx sources compounded semaglutide from licensed 503A pharmacies that follow FDA manufacturing standards for purity, potency, and sterility. Compounded and brand-name semaglutide contain the identical active ingredient and work the same way. The main difference is cost: compounded semaglutide from PlexusDx is $189/mo month-to-month, or from $149/mo on the 6-month plan, compared to $1,000+/mo for Wegovy, making it accessible to far more people.

How long does it take to see weight loss results with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I use PlexusDx semaglutide if I have type 2 diabetes?

Yes, semaglutide is safe and beneficial for people with type 2 diabetes, as it improves blood sugar control while supporting weight loss. However, if you take insulin or other diabetes medications, your doctor may need to adjust those dosages as your blood sugar improves. PlexusDx requires a consultation with a licensed practitioner who reviews your diabetes management and coordinates care with your primary care doctor.

What happens if I stop taking semaglutide?

When you stop semaglutide, appetite hormones gradually return to baseline over several weeks, and some weight regain typically occurs. However, clinical data shows that many people retain 50% or more of the weight they lost. To maintain long-term results, semaglutide is best used as an ongoing therapy. PlexusDx supports flexible commitment options so you can adjust your treatment as your goals evolve.

How does the PlexusDx Precision Peptide Genetic Test improve my results?

The Precision Peptide Genetic Test analyzes 14 metabolic pathways and 150+ genetic insights, including variants in MC4R and FTO, and GIPR genes that influence how well you respond to semaglutide and how your body regulates appetite. This test ($298) identifies whether you are a high-responder, whether combination therapy might work better, and which lifestyle changes align with your genetics—removing guesswork and accelerating your results.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.